The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
5 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $7,070,333 in first-year total cost, median $1,413,547.
Most frequent study sections
- Special Emphasis Panel[ZCA1 RTRB-Y (M1)]3
- Special Emphasis Panel[ZCA1 RTRB-U (J2)]2
Most frequent institutions
- UNIVERSITY OF PENNSYLVANIA2
- MASSACHUSETTS GENERAL HOSPITAL1
- SLOAN-KETTERING INST CAN RESEARCH1
- UNIVERSITY OF TX MD ANDERSON CAN CTR1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | CD28-KITv CAR T cells with PD-1 dominant negative receptor1UG3CA290241-01 | ADUSUMILLI, PRASAD S. | SLOAN-KETTERING INST CAN RESEARCH, NY | $1,491,519 | ZCA1 |
| 2024 | Dual-targeted DOTA CAR T cells with image-guided monitoring for solid tumor treatment1UG3CA290451-01 | FARWELL, MICHAEL DAVIDPOWELL, DANIEL J. | UNIVERSITY OF PENNSYLVANIA, PA | $1,453,091 | ZCA1 |
| 2023 | CAR T cells targeting mesothelin and secreting bispecific antibodies targeting fibroblasts in pancreatic cancer1UG3CA283619-01 | MAUS, MARCELA VALDERRAMA | MASSACHUSETTS GENERAL HOSPITAL, MA | $1,413,547 | ZCA1 |
| 2023 | HORMAD-specific TGF-beta resistant memory T cells for treatment of patients with Gastro-esophageal Cancer1UG3CA283615-01 | MORELLI, MARIA PIARAI, KUNALYEE, CASSIAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $1,406,916 | ZCA1 |
| 2023 | Next generation T cell therapies for mutant KRAS solid tumors1UG3CA283652-01 | CARRENO, BEATRIZ M.JUNE, CARL H.LINETTE, GERALD P | UNIVERSITY OF PENNSYLVANIA, PA | $1,305,260 | ZCA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.